Nippon Shinyaku Co's EBIT per Share for the
three
months ended in Mar. 2026 was MXN5.53.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was MXN66.23.
During the past 12 months, the average EBIT per Share Growth Rate of Nippon Shinyaku Co was 0.10% per year.
During the past 3 years, the average EBIT per Share Growth Rate was 5.70% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 4.80% per year.
During the past 10 years, the average EBIT per Share Growth Rate was 13.20% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Nippon Shinyaku Co's EBIT per Share or its related term are showing as below:
MEX:4516N'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -26.3 Med: 7.5 Max: 34.2
Current: 5.7
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Nippon Shinyaku Co was 34.20% per year. The lowest was -26.30% per year. And the median was 7.50% per year.
MEX:4516N's 3-Year EBIT Growth Rate is ranked worse than 53.03% of 809
companies
in the Drug Manufacturers industry
Industry Median: 7.5
vs MEX:4516N: 5.70
Nippon Shinyaku Co (MEX:4516N) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Nippon Shinyaku Co EBIT per Share Related Terms
Nippon Shinyaku Co EBIT per Share Historical Data
* Premium members only.
The historical data trend for Nippon Shinyaku Co's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN66.23
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nippon Shinyaku Co (MEX:4516N) has a EBIT per Share of MXN66.23 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Nippon Shinyaku Co and its competitors. According to the industry distribution chart, Nippon Shinyaku Co ranks #429 out of 809 companies in the Drug Manufacturers industry, placing it in the top 53%.
Is Nippon Shinyaku Co's EBIT per Share too high?
Nippon Shinyaku Co's current EBIT per Share is MXN66.23. Based on the distribution chart, Nippon Shinyaku Co ranks #429 out of 809 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Nippon Shinyaku Co has a GF Score™ of 92/100, reflecting its overall financial health beyond just this single metric.
How does Nippon Shinyaku Co's EBIT per Share compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Nippon Shinyaku Co ranks #429 out of 809 companies for EBIT per Share. This places Nippon Shinyaku Co in the lower half of its industry. The industry median EBIT per Share is 7.50. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Drug Manufacturers company?
The median EBIT per Share among Drug Manufacturers companies is 7.50, based on 809 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Nippon Shinyaku Co and its competitors. For the Drug Manufacturers industry, the median EBIT per Share is 7.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nippon Shinyaku Co's current EBIT per Share is MXN66.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nippon Shinyaku Co stock overvalued right now?
Nippon Shinyaku Co (MEX:4516N) has a current EBIT per Share of MXN66.23. The stock's GF Value™ is MXN553.48, compared to a current price of MXN468.31 — trading 15.4% below its estimated fair value. The current EBIT per Share is MXN66.23. Nippon Shinyaku Co's overall GF Score™ is 92/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Nippon Shinyaku Co (MEX:4516N), the current EBIT per Share is MXN66.23 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nippon Shinyaku Co (MEX:4516N) Overvalued in 2026?
Based on GuruFocus' analysis, Nippon Shinyaku Co stock appears to be undervalued.
The current stock price of MXN468.31 is trading 15.4% below its estimated GF Value™ of MXN553.48.
Key valuation signals for MEX:4516N:
EBIT per Share: MXN66.23
GF Value™: MXN553.48 vs. price of MXN468.31 (15.4% below fair value)
No single metric tells the full story. See the MEX:4516N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nippon Shinyaku Co Ltd is engaged in the pharmaceuticals and functional food businesses. The Pharmaceuticals Business develops and sells treatments for urological disorders, blood cancer, rare and intractable diseases, and gynecological conditions. The Functional Food Business produces and sells health food ingredients, quality-stabilizing preservatives, protein preparations, and supplements. It generates the majority of its revenue from the Pharmaceuticals segment.
92GF Score
Get the complete analysis for MEX:4516N
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:4516N has been successfully added to your 
